The Chemours financials at a glance
| Year | Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2014 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$5.72B | $5.40B | $6.18B | $6.64B | $5.53B | $4.97B | $6.35B | $6.79B | $6.03B | $6.43B | $0.00M |
| GM % | Gross Margin % |
|
16.70% | 20.43% | 28.22% | 29.69% | 19.24% | 21.47% | 21.77% | 23.79% | 21.67% | 21.14% | 0.00% |
| OM | Operating Margin |
|
3.95% | 7.98% | 17.34% | 18.97% | 1.21% | 9.58% | 10.87% | 11.67% | 11.17% | 8.27% | 0.00% |
| EPS | Earnings Per Share |
|
$0.79 | $1.02 | $3.82 | $5.67 | $2.51 | $1.98 | $4.00 | $4.66 | $2.82 | $0.00 | |
| Div. | Dividends |
|
$0.58 | $0.12 | $0.17 | $0.84 | $1.00 | $1.00 | $1.00 | $1.00 | $0.99 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
73.42% | 11.76% | 4.45% | 14.81% | 39.84% | 50.51% | 25.00% | 21.46% | 35.11% | 0 | 0 |
| Sha. | Shares |
|
180.99m | 181.83m | 185.16m | 171.08m | 163.5m | 164.22m | 162.96m | 150.92m | 148.44m | 0m | 148.44m |
| OCF | Operating Cash Flow |
|
$182.00M | $594.00M | $640.00M | $1.14B | $650.00M | $807.00M | $820.00M | $754.00M | $556.00M | $505.00M | $0.00M |
| FCF | Free Cash Flow |
|
$-337.00M | $256.00M | $228.00M | $642.00M | $169.00M | $540.00M | $543.00M | $447.00M | $100.67M | $-99.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-1.86 | $1.41 | $1.24 | $3.63 | $1.03 | $3.28 | $3.29 | $2.88 | $1.25 | $-0.55 | $0.00 |